Male Pattern Baldness

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Male Pattern Baldness trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

RecruitingPhase 1/2

NCT07317544

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

The goal of this clinical trial is to learn if ABS-201 (a new medication) is safe and tolerable when used to improve hair growth in men and women. The trial wil…

Australia227 participantsStarted 2025-12-03

Treatment: ABS-201 IV Single Dose, Placebo IV

RecruitingNot Applicable

NCT07502976

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Androgenetic alopecia is a common form of hair loss that can affect quality of life. This randomized controlled trial aims to evaluate the efficacy and safety o…

Egypt60 participantsStarted 2026-01-01

Treatment: Topical 2-Deoxy-D-ribose Hydrogel, Topical Minoxidil 5% Solution

RecruitingPhase 3

NCT07435012

Androgenic Alopecia TH07 Clinical Trial

The goal of this clinical trial is to learn whether a new topical solution, TH07, can help treat androgenic alopecia in men and to learn more about its safety.…

Canada420 participantsStarted 2026-04

Treatment: TH07, TH07

RecruitingPhase 1/2

NCT07327359

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

This study is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of OLX72021 in medically healthy men with mild to moderate androgenetic a…

Australia158 participantsStarted 2025-12-04

Treatment: OLX72021, OLX72021

RecruitingPhase 3

NCT06924632

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

This is a phase 3, multicentre, randomised, double-blinded, placebo-controlled study examining the safety and efficacy of 2.5 mg sublingual (SL) minoxidil table…

Australia132 participantsStarted 2025-07-14

Treatment: Minoxidil, Placebo

All recent trials (100 shown)

Not Yet RecruitingPhase 3

NCT07529977

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

This study is a Phase 3 clinical trial designed to evaluate the efficacy and safety of N1087 compared with placebo in adult men with androgenetic alopecia (male…

Location not specified372 participantsStarted 2027-01-31

Treatment: Minoxidil oral solution, Placebo oral solution

Not Yet RecruitingPhase 4

NCT07518342

The Effect of Nanofat Injection on Androgenetic Alopecia

Androgenetic alopecia is a condition that bothers a lot of people. The disadvantage of the FDA approved topical minoxidil is that the patient needs to be compli…

Egypt60 participantsStarted 2026-04

Treatment: Minoxidil 5 %, PRP injection

Male Pattern Baldness

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Androgenic Alopecia TH07 Clinical Trial

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

All recent trials (100 shown)

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

The Effect of Nanofat Injection on Androgenetic Alopecia

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Androgenic Alopecia TH07 Clinical Trial

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

All recent trials (100 shown)

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

The Effect of Nanofat Injection on Androgenetic Alopecia

Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia

Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

Safety and Efficacy of VDPHL01 in Males With AGA

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

Safety and Efficacy of VDPHL01 in Males and Females With AGA

Efficacy and Safety of VDPHL01 in Males With AGA

Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

Evaluation of the Niostem Headset for Hair Growth and Hair Quality

A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia

Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss

1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss